Marathon Sells DMD Drug Deflazacort to PTC Following Price Hike Criticism
Following widespread criticism for its price hike in its recently purchased Duchenne drug, Deflazacort, Marathon have agreed terms to...
top of page
Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
bottom of page